High Tower Advisors, LLC Biolife Solutions Inc Transaction History

High Tower Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$15.14 - $22.99 $192,535 - $292,363	12,717 New	12,717 $272,000
Q3 2023 Nov 08, 2023	BUY	$10.81 - $22.96 $190,655 - $404,945	17,637 New	17,637 $243,000
Q4 2022 Feb 08, 2023	BUY	$16.95 - $25.07 $429,411 - $635,123	25,334 New	25,334 $461,000
Q2 2022 Aug 10, 2022	BUY	$10.54 - $24.2 $847,985 - $1.95 Million	80,454 Added 604.33%	93,767 $1.29 Million
Q1 2022 May 12, 2022	BUY	$20.81 - $37.29 $163,483 - $292,950	7,856 Added 143.96%	13,313 $302,000
Q4 2021 Feb 10, 2022	SELL	$32.99 - $58.55 $626 - $1,112	-19 Reduced 0.35%	5,457 $204,000
Q3 2021 Nov 12, 2021	BUY	$42.03 - $60.5 $7,691 - $11,071	183 Added 3.46%	5,476 $231,000
Q2 2021 Aug 06, 2021	BUY	$29.51 - $44.62 $156,196 - $236,173	5,293 New	5,293 $235,000
Q1 2021 May 10, 2021	SELL	$32.95 - $44.24 $165,178 - $221,775	-5,013 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$27.5 - $45.75 $137,857 - $229,344	5,013 New	5,013 $200,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.16B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.